Cargando…
Necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices
We have demonstrated that retrospective evaluation of existing data of in vitro chromosomal aberration test using the new cytotoxicity indices RICC (relative increase in cell count) or RPD (relative population doubling) reduces the false-positive rate. We have constructed an algorithm to predict the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761126/ https://www.ncbi.nlm.nih.gov/pubmed/29339977 http://dx.doi.org/10.1186/s41021-017-0091-y |
_version_ | 1783291505596694528 |
---|---|
author | Honda, Hiroshi Fujita, Yurika Kasamatsu, Toshio Fuchs, Anne Fautz, Rolf Morita, Osamu |
author_facet | Honda, Hiroshi Fujita, Yurika Kasamatsu, Toshio Fuchs, Anne Fautz, Rolf Morita, Osamu |
author_sort | Honda, Hiroshi |
collection | PubMed |
description | We have demonstrated that retrospective evaluation of existing data of in vitro chromosomal aberration test using the new cytotoxicity indices RICC (relative increase in cell count) or RPD (relative population doubling) reduces the false-positive rate. We have constructed an algorithm to predict the likelihood that past-positive results would differ when retested accordingly. Here, we emphasize the importance of reviewing existing in vitro chromosomal aberration test results. The present Letter not only supports the rediscovery of potentially useful chemicals excluded from further development as a result of misclassification due to in vitro false-positive results, but also contributes to the development of a precise Quantitative Structure-Activity Relationship (QSAR) model by providing an appropriate training data-set. Furthermore, re-evaluation is expected to provide novel insights into underlying mechanisms and/or key structures involved in the development of chromosomal aberrations. |
format | Online Article Text |
id | pubmed-5761126 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57611262018-01-16 Necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices Honda, Hiroshi Fujita, Yurika Kasamatsu, Toshio Fuchs, Anne Fautz, Rolf Morita, Osamu Genes Environ Letter to the Editor We have demonstrated that retrospective evaluation of existing data of in vitro chromosomal aberration test using the new cytotoxicity indices RICC (relative increase in cell count) or RPD (relative population doubling) reduces the false-positive rate. We have constructed an algorithm to predict the likelihood that past-positive results would differ when retested accordingly. Here, we emphasize the importance of reviewing existing in vitro chromosomal aberration test results. The present Letter not only supports the rediscovery of potentially useful chemicals excluded from further development as a result of misclassification due to in vitro false-positive results, but also contributes to the development of a precise Quantitative Structure-Activity Relationship (QSAR) model by providing an appropriate training data-set. Furthermore, re-evaluation is expected to provide novel insights into underlying mechanisms and/or key structures involved in the development of chromosomal aberrations. BioMed Central 2018-01-10 /pmc/articles/PMC5761126/ /pubmed/29339977 http://dx.doi.org/10.1186/s41021-017-0091-y Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Letter to the Editor Honda, Hiroshi Fujita, Yurika Kasamatsu, Toshio Fuchs, Anne Fautz, Rolf Morita, Osamu Necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices |
title | Necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices |
title_full | Necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices |
title_fullStr | Necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices |
title_full_unstemmed | Necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices |
title_short | Necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices |
title_sort | necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761126/ https://www.ncbi.nlm.nih.gov/pubmed/29339977 http://dx.doi.org/10.1186/s41021-017-0091-y |
work_keys_str_mv | AT hondahiroshi necessityforretrospectiveevaluationofpastpositivechemicalsininvitrochromosomalaberrationtestsusingrecommendedcytotoxicityindices AT fujitayurika necessityforretrospectiveevaluationofpastpositivechemicalsininvitrochromosomalaberrationtestsusingrecommendedcytotoxicityindices AT kasamatsutoshio necessityforretrospectiveevaluationofpastpositivechemicalsininvitrochromosomalaberrationtestsusingrecommendedcytotoxicityindices AT fuchsanne necessityforretrospectiveevaluationofpastpositivechemicalsininvitrochromosomalaberrationtestsusingrecommendedcytotoxicityindices AT fautzrolf necessityforretrospectiveevaluationofpastpositivechemicalsininvitrochromosomalaberrationtestsusingrecommendedcytotoxicityindices AT moritaosamu necessityforretrospectiveevaluationofpastpositivechemicalsininvitrochromosomalaberrationtestsusingrecommendedcytotoxicityindices |